Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umang G Thakkar

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Biomedical Journal|August 14, 2014
Co-infusion of autologous adipose tissue derived neuronal differentiated mesenchymal stem cells and bone marrow derived hematopoietic stem cells, a viable therapy for post-traumatic brachial plexus injury: a case reportUmang G Thakkar, Aruna V Vanikar, Hargovind L Trivedi
Diabetes Research and Clinical Practice|June 16, 2017
Stem cells: An emerging novel therapeutic for type-1 diabetes mellitusUmang G Thakkar, Aruna V Vanikar, Hargovind L Trivedi
Puerto Rico Health Sciences Journal|November 26, 2015
Anaphylactoid Purpura Manifested after Acute Gastroenteritis with Severe Dehydration in an 8-Year-Old Male Child: A Case ReportUmang G Thakkar, Aruna V Vanikar, Hargovind L Trivedi
Clinical Immunology (Orlando, Fla.)|August 1, 2017
Six years' experience of tolerance induction in renal transplantation using stem cell therapyAruna V Vanikar, Hargovind L Trivedi, Umang G Thakkar
Cytotherapy|July 18, 2016
Stem cell therapy emerging as the key player in treating type 1 diabetes mellitusAruna V Vanikar, Hargovind L Trivedi, Umang G Thakkar
Cytotherapy|January 17, 2017
Stem cell therapy: An emerging modality in glomerular diseasesUmang G Thakkar, Aruna V Vanikar, Hargovind L Trivedi
Biomedical Journal|January 4, 2014
Co-infusion of autologous adipose tissue derived insulin-secreting mesenchymal stem cells and bone marrow derived hematopoietic stem cells: viable therapy for type III.C. a diabetes mellitusUmang G Thakkar, Aruna V Vanikar, Hargovind L Trivedi
Current Stem Cell Research & Therapy|December 2, 2016
In vitro Generated Mesenchymal Stem Cells: Suitable Tools to Target Insulin Dependent Diabetes Mellitus?Shruti D Dave, Chetan N Patel, Jignesh V Patel, et al.
Cytotherapy|April 15, 2015
Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitusUmang G Thakkar, Hargovind L Trivedi, Aruna V Vanikar, et al.
BMJ Case Reports|June 9, 2012
Treatment of polyglandular autoimmune syndrome type 3 using co-transplantation of insulin-secreting mesenchymal stem cells and haematopoietic stem cellsHargovind L Trivedi, Umang G Thakkar, Aruna V Vanikar, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Biomedical Journal|August 14, 2014
Co-infusion of autologous adipose tissue derived neuronal differentiated mesenchymal stem cells and bone marrow derived hematopoietic stem cells, a viable therapy for post-traumatic brachial plexus injury: a case reportUmang G Thakkar, Aruna V Vanikar, Hargovind L Trivedi
Diabetes Research and Clinical Practice|June 16, 2017
Stem cells: An emerging novel therapeutic for type-1 diabetes mellitusUmang G Thakkar, Aruna V Vanikar, Hargovind L Trivedi
Puerto Rico Health Sciences Journal|November 26, 2015
Anaphylactoid Purpura Manifested after Acute Gastroenteritis with Severe Dehydration in an 8-Year-Old Male Child: A Case ReportUmang G Thakkar, Aruna V Vanikar, Hargovind L Trivedi
Clinical Immunology (Orlando, Fla.)|August 1, 2017
Six years' experience of tolerance induction in renal transplantation using stem cell therapyAruna V Vanikar, Hargovind L Trivedi, Umang G Thakkar
Cytotherapy|July 18, 2016
Stem cell therapy emerging as the key player in treating type 1 diabetes mellitusAruna V Vanikar, Hargovind L Trivedi, Umang G Thakkar
Cytotherapy|January 17, 2017
Stem cell therapy: An emerging modality in glomerular diseasesUmang G Thakkar, Aruna V Vanikar, Hargovind L Trivedi
Biomedical Journal|January 4, 2014
Co-infusion of autologous adipose tissue derived insulin-secreting mesenchymal stem cells and bone marrow derived hematopoietic stem cells: viable therapy for type III.C. a diabetes mellitusUmang G Thakkar, Aruna V Vanikar, Hargovind L Trivedi
Current Stem Cell Research & Therapy|December 2, 2016
In vitro Generated Mesenchymal Stem Cells: Suitable Tools to Target Insulin Dependent Diabetes Mellitus?Shruti D Dave, Chetan N Patel, Jignesh V Patel, et al.
Cytotherapy|April 15, 2015
Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitusUmang G Thakkar, Hargovind L Trivedi, Aruna V Vanikar, et al.
BMJ Case Reports|June 9, 2012
Treatment of polyglandular autoimmune syndrome type 3 using co-transplantation of insulin-secreting mesenchymal stem cells and haematopoietic stem cellsHargovind L Trivedi, Umang G Thakkar, Aruna V Vanikar, et al.
Pageof 2